Insider Transactions in Q2 2021 at Centene Corp (CNC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+1.73%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
620
+0.09%
|
$42,160
$68.51 P/Share
|
|
Jun 30
2021
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+0.23%
|
$34,680
$68.51 P/Share
|
|
Jun 30
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.14%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.5%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+0.22%
|
$34,680
$68.51 P/Share
|
|
Jun 30
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.21%
|
$31,008
$68.51 P/Share
|
|
Jun 23
2021
|
Brent D Layton President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+3.04%
|
$972,000
$72.2 P/Share
|
|
Jun 23
2021
|
Christopher Koster Secretary & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+9.09%
|
$972,000
$72.2 P/Share
|
|
Jun 23
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+11.26%
|
$972,000
$72.2 P/Share
|
|
Jun 21
2021
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,238
-0.59%
|
$158,898
$71.69 P/Share
|
|
Jun 18
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
13,550
+8.7%
|
-
|
|
Jun 18
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
13,550
-88.05%
|
-
|
|
Jun 15
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
30,000
-23.03%
|
$2,070,000
$69.01 P/Share
|
|
Jun 11
2021
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Open market or private sale
|
Direct |
25,000
-5.72%
|
$1,775,000
$71.17 P/Share
|
|
May 27
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
6,510
+29.73%
|
-
|
|
May 27
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
6,510
-4.81%
|
-
|
|
May 12
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Bona fide gift
|
Direct |
50
-0.0%
|
-
|
|
May 07
2021
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
SELL
Open market or private sale
|
Direct |
18,000
-3.81%
|
$1,242,000
$69.0 P/Share
|
|
May 07
2021
|
Andrew Lynn Asher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+17.6%
|
$3,250,000
$65.19 P/Share
|
|
May 07
2021
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
15,000
-8.36%
|
$1,020,000
$68.0 P/Share
|
|
May 07
2021
|
John R Roberts Director |
SELL
Open market or private sale
|
Indirect |
5,000
-36.03%
|
$350,000
$70.0 P/Share
|
|
May 06
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
3,300
+37.08%
|
-
|
|
May 06
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Direct |
3,300
-1.52%
|
-
|
|
May 05
2021
|
Brent D Layton President & COO |
SELL
Open market or private sale
|
Direct |
7,682
-1.81%
|
$499,330
$65.0 P/Share
|
|
Apr 29
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
7,201
-5.24%
|
$432,060
$60.0 P/Share
|
|
Apr 29
2021
|
Michael F Neidorff Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,166
+0.11%
|
$623,304
$44.07 P/Share
|
|
Apr 27
2021
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,188
-8.43%
|
$738,408
$66.0 P/Share
|
|
Apr 27
2021
|
Orlando Ayala Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+2.34%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Jessica L. Blume Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+16.58%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+11.5%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+0.49%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+0.98%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Richard A Gephardt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+5.0%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Lori Jean Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+27.31%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.49%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.44%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+3.5%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.5%
|
$217,800
$66.0 P/Share
|
|
Apr 15
2021
|
Brent D Layton President & COO |
SELL
Bona fide gift
|
Direct |
795
-0.19%
|
-
|
|
Apr 05
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Bona fide gift
|
Direct |
15,650
-0.24%
|
-
|
|
Apr 01
2021
|
Katie Casso Corporate Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
6,259
+13.13%
|
$394,317
$63.91 P/Share
|